George Hardie

442 total citations
20 papers, 298 citations indexed

About

George Hardie is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, George Hardie has authored 20 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 10 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in George Hardie's work include Smoking Behavior and Cessation (18 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Air Quality and Health Impacts (5 papers). George Hardie is often cited by papers focused on Smoking Behavior and Cessation (18 papers), Nicotinic Acetylcholine Receptors Study (10 papers) and Air Quality and Health Impacts (5 papers). George Hardie collaborates with scholars based in United Kingdom, United States and Italy. George Hardie's co-authors include Michael McEwan, Nathan Gale, James J. Murphy, Oscar M. Camacho, Christopher Proctor, David Azzopardi, Ian M. Fearon, Linsey E. Haswell, Zvi R. Cohen and Annette Dalrymple and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Nicotine & Tobacco Research.

In The Last Decade

George Hardie

18 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Hardie United Kingdom 11 241 99 86 45 42 20 298
Nathan Gale United Kingdom 14 361 1.5× 134 1.4× 115 1.3× 95 2.1× 61 1.5× 21 441
Raheema Muhammad-Kah United States 11 168 0.7× 90 0.9× 45 0.5× 60 1.3× 28 0.7× 14 311
Tameka S. Lawler United States 7 222 0.9× 90 0.9× 54 0.6× 79 1.8× 14 0.3× 8 337
Nadja Mallock Germany 7 181 0.8× 40 0.4× 82 1.0× 54 1.2× 12 0.3× 9 245
Helena Digard United Kingdom 8 195 0.8× 57 0.6× 35 0.4× 95 2.1× 41 1.0× 11 330
David Azzopardi United Kingdom 10 268 1.1× 123 1.2× 79 0.9× 148 3.3× 103 2.5× 15 467
Elke Pieper Germany 7 114 0.5× 23 0.2× 62 0.7× 36 0.8× 7 0.2× 10 171
Wanzhe Zhu United States 7 88 0.4× 26 0.3× 39 0.5× 58 1.3× 12 0.3× 20 193
Haesook Min South Korea 11 65 0.3× 35 0.4× 94 1.1× 13 0.3× 15 0.4× 15 257
Stacy Fiebelkorn United Kingdom 6 139 0.6× 52 0.5× 36 0.4× 142 3.2× 29 0.7× 12 317

Countries citing papers authored by George Hardie

Since Specialization
Citations

This map shows the geographic impact of George Hardie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Hardie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Hardie more than expected).

Fields of papers citing papers by George Hardie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Hardie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Hardie. The network helps show where George Hardie may publish in the future.

Co-authorship network of co-authors of George Hardie

This figure shows the co-authorship network connecting the top 25 collaborators of George Hardie. A scholar is included among the top collaborators of George Hardie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Hardie. George Hardie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azzopardi, David, Elaine Brown, Stacy Fiebelkorn, et al.. (2025). A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers. The Journal of Clinical Pharmacology. 66(1). e70090–e70090.
2.
McEwan, Michael, et al.. (2023). Assessing the impact of protonating acid combinations in e-cigarette liquids: a randomised, crossover study on nicotine pharmacokinetics. Scientific Reports. 13(1). 10563–10563. 4 indexed citations
3.
McEwan, Michael, et al.. (2023). Plasma Nicotine Pharmacokinetics of Oral Nicotine Pouches Across Varying Flavours and Nicotine Content *. SHILAP Revista de lepidopterología. 32(4). 130–139. 2 indexed citations
4.
Haswell, Linsey E., Nathan Gale, Elaine Brown, et al.. (2023). Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers. Internal and Emergency Medicine. 18(5). 1359–1371. 3 indexed citations
5.
Hardie, George, Nathan Gale, Michael McEwan, et al.. (2022). An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy. Scientific Reports. 12(1). 14701–14701. 10 indexed citations
6.
Gale, Nathan, Michael McEwan, George Hardie, Christopher Proctor, & James J. Murphy. (2022). Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking. Internal and Emergency Medicine. 17(7). 2017–2030. 24 indexed citations
7.
8.
Dalrymple, Annette, et al.. (2022). Pilot study to determine differences in breath odour between cigarette and e-cigarette consumers. Scientific Reports. 12(1). 2204–2204. 2 indexed citations
9.
Azzopardi, David, Michael McEwan, Oscar M. Camacho, et al.. (2022). A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products. Scientific Reports. 12(1). 6949–6949. 31 indexed citations
10.
11.
12.
McEwan, Michael, Nathan Gale, Oscar M. Camacho, et al.. (2021). A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation. Toxicology Reports. 8. 994–1001. 25 indexed citations
13.
Dalrymple, Annette, et al.. (2021). A novel clinical method to measure skin staining reveals activation of skin damage pathways by cigarette smoke. Skin Research and Technology. 28(1). 162–170. 11 indexed citations
14.
Gale, Nathan, Michael McEwan, Oscar M. Camacho, et al.. (2021). Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Internal and Emergency Medicine. 16(8). 2201–2212. 36 indexed citations
15.
McEwan, Michael, David Azzopardi, Nathan Gale, et al.. (2021). A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette. European Journal of Drug Metabolism and Pharmacokinetics. 47(2). 211–221. 40 indexed citations
16.
17.
Gale, Nathan, Michael McEwan, Oscar M. Camacho, et al.. (2020). Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to the glo Tobacco Heating Product: A Randomized, Controlled Ambulatory Study. Nicotine & Tobacco Research. 23(3). 584–591. 41 indexed citations
18.
Lowe, Frazer, Oscar M. Camacho, Nathan Gale, et al.. (2019). Evaluating the effects of switching from cigarette smoking to using a heated tobacco product on health effect indicators in healthy subjects: study protocol for a randomized controlled trial. Internal and Emergency Medicine. 14(6). 885–898. 20 indexed citations
19.
Hardie, George, et al.. (2019). Evaluating the Moisturizing Abilities and Sun Protection Factor of New Lip Balm Formulations.. PubMed. 70(1). 1–15. 3 indexed citations
20.
Hardie, George, et al.. (1978). Hands Across the Water : Wings Tour USA. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Gale Breakdown of academic impact, for papers by Raheema Muhammad-Kah Breakdown of academic impact, for papers by Tameka S. Lawler Breakdown of academic impact, for papers by Nadja Mallock Breakdown of academic impact, for papers by Helena Digard Breakdown of academic impact, for papers by David Azzopardi Breakdown of academic impact, for papers by Elke Pieper Breakdown of academic impact, for papers by Wanzhe Zhu Breakdown of academic impact, for papers by Haesook Min Breakdown of academic impact, for papers by Stacy Fiebelkorn
Rankless by CCL
2026